Viroblock's Series C - II Round

Viroblock raised a round of funding on February 28, 2012. Investors include StartAngels Network.

Viroblock develops an anti-microbial fabric based on its cholesterol sequestration technology capable of inactivating H5N1 and other enveloped viruses on pass through air. Unlike regular face-masks th…

Articles about Viroblock's Series C - II Round: